Metraipolis › archive › dc_438d76335377

Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024) — Europe PMC PMID:42131761

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42131761
DOI
10.1093/nop/npaf099
License (as archived)
solo-consultazione
Archived
2026-11-09T18:24:55.587Z
SHA-256 of the archived text
4133db8e0127c1609a119e84aca77adaf1749fde991fef9fc57530c25e638ed3
Stable URL of this page
https://metraipolis.com/documento/dc_438d76335377

How to cite

Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024) — Europe PMC PMID:42131761 — Europe PMC (en), https://europepmc.org/article/MED/42131761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_438d76335377 (Metraipolis archive dc_438d76335377, sha256 4133db8e0127c1609a119e84aca77adaf1749fde991fef9fc57530c25e638ed3)
BibTeX
@misc{dc438d76335377,
  title = {Transforming molecular neuropathology for adult brain tumor patients in the UK: Insights on implementation, adoption, and patient access (2021-2024) — Europe PMC PMID:42131761},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42131761},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_438d76335377; sha256 4133db8e0127c1609a119e84aca77adaf1749fde991fef9fc57530c25e638ed3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42131761. Agents can read the archived copy with the MCP tool read_document.